Cargando…
Cerebrolysin administration reduces oxidative stress-induced apoptosis in limphocytes from healthy individuals
Cerebrolysin is the only drug available for clinical use containing active fragments of some important neurotrophic factors obtained from purified porcine brain proteins, which has long been used for the treatment of dementia and stroke sequels. Cerebrolysin has growth factor-like activities and pro...
Autores principales: | Formichi, Patrizia, Radi, Elena, Battisti, Carla, Di Maio, Giuseppe, Muresanu, Dafin, Federico, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4118252/ https://www.ncbi.nlm.nih.gov/pubmed/22882711 http://dx.doi.org/10.1111/j.1582-4934.2012.01615.x |
Ejemplares similares
-
Altered apoptosis regulation in Kufor–Rakeb syndrome patients with mutations in the ATP13A2 gene
por: Radi, Elena, et al.
Publicado: (2012) -
Role and Impact of Cerebrolysin for Ischemic Stroke Care
por: Mureșanu, Dafin F., et al.
Publicado: (2022) -
Cost-Effectiveness of Cerebrolysin after Ischemic Stroke: Secondary Analysis of the CARS Study
por: Strilciuc, Stefan, et al.
Publicado: (2023) -
Cerebrolysin and repetitive transcranial magnetic stimulation (rTMS) in patients with traumatic brain injury: a three-arm randomized trial
por: Verisezan Rosu, Olivia, et al.
Publicado: (2023) -
Efficacy and safety of Cerebrolysin in
patients with hemorrhagic stroke
por: Bajenaru, O, et al.
Publicado: (2010)